CONTACT | CERTIFICATIONS | DOWNLOAD |

Cerifications | Download

aorticlab-logo-claim
  • HOME
  • ABOUT US
    • Mission, Vision, Values
    • Our Team
    • Board
  • AORTICLAB SOLUTIONS
    • FLOWer
    • TDD
  • FLOWer-EDUCATION
    • Patients
    • Healthcare Professionals
    • Clinical Evidence
  • NEWS
    • Press Releases
    • Press Material
  • CONTACT
    • Distributors
    • Partners
  • HOME
  • ABOUT US
    • Mission, Vision, Values
    • Our Team
    • Board
  • AORTICLAB SOLUTIONS
    • FLOWer
    • TDD
  • FLOWer-EDUCATION
    • Patients
    • Healthcare Professionals
    • Clinical Evidence
  • NEWS
    • Press Releases
    • Press Material
  • CONTACT
    • Distributors
    • Partners

03 Feb Trans-Catheter Double-Frequency Ultrasound Ablator for The Treatment of Aortic Valve Leaflets Calcification

Posted at 09:41h in clinical, News by Aorticlab
0 Likes

Degenerative aortic stenosis (AS) is the most common heart valve disease in developed countries. The prevalence of AS increases with age and varies from 0.2% at ages 50 to 59 years to 1.3% at 60 to 69 years, 3.9% at 70 to 79 years, and...

Read More
  • Via Ribes, 5, 10010 Colleretto Giacosa TO, Italy
  • +39 011 1883 8598
  • info@aorticlab.ch
Legal
  • Imprint
  • Privacy Policy
  • Cookies (EU)
  • Whistelblowing
  • Code of Ethics
  • Imprint
  • Privacy Policy
  • Cookies (EU)
  • Whistelblowing
  • Code of Ethics
Information
  • Contact
  • Career
  • Sources
  • Sitemap
  • Contact
  • Career
  • Sources
  • Sitemap

© AorticLab 2025

Certificates